RxDoctor Payments Data

Kevin Davis, PA

Medical · Hindman, KYNPI 1811903529

Payments from drug & device makers

$1,159in general payments, 2019–2025

Across 65 payments — averaging $17.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$194
  • AstraZeneca$152
  • Vanda Pharmaceuticals Inc.$149
  • Grifols USA, LLC$102
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$90
  • Lilly USA, LLC$88
  • plus $385 from 12 others

What the payments were for

  • Food & beverage$1,159100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,159 in reported general payments places this provider in the 55th percentile of 222 medical providers in Kentucky.

See all medical providers in Kentucky

Medicare billing

Part B allowed, 2024
$16,832
Medicare patients
104
Services billed
1,118

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol112$130,105
Humira PenAdalimumab15$103,398
OzempicSemaglutide79$82,691
Enbrel SureclickEtanercept11$80,631
MounjaroTirzepatide57$61,405
JanuviaSitagliptin Phosphate23$33,321
EliquisApixaban18$24,272
Bydureon BciseExenatide Microspheres14$17,424
InvokanaCanagliflozin17$14,463
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$10,220
MyrbetriqMirabegron14$8,209
LinzessLinaclotide13$7,891
SymbicortBudesonide/Formoterol Fumarate24$6,332
Combivent RespimatIpratropium/Albuterol Sulfate12$5,715
Omega-3 Acid Ethyl Esters60$4,669

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Symbicort$152$136,436136 claims
Novo NordiskOzempic$41$82,69179 claims
Lilly USA, LLCMounjaro$88$61,40557 claims
PfizerEliquis, Paxlovid$56$25,66459 claims
GSKTrelegy Ellipta$42$10,22015 claims
AbbVieLinzess$194$7,89113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 222 medical providers in Kentucky.

Other medical in Hindman

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →